Found: 11
Select item for more details and to access through your institution.
Efgartigimod: A Review in Generalised Myasthenia Gravis.
- Published in:
- Drugs, 2024, v. 84, n. 11, p. 1463, doi. 10.1007/s40265-024-02101-9
- By:
- Publication type:
- Article
Seladelpar: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 11, p. 1487, doi. 10.1007/s40265-024-02114-4
- By:
- Publication type:
- Article
Vunakizumab: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 11, p. 1481, doi. 10.1007/s40265-024-02110-8
- By:
- Publication type:
- Article
Axatilimab: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 11, p. 1475, doi. 10.1007/s40265-024-02109-1
- By:
- Publication type:
- Article
How Psychedelics Modulate Multiple Memory Mechanisms in Posttraumatic Stress Disorder.
- Published in:
- Drugs, 2024, v. 84, n. 11, p. 1419, doi. 10.1007/s40265-024-02106-4
- By:
- Publication type:
- Article
Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action.
- Published in:
- Drugs, 2024, v. 84, n. 11, p. 1395, doi. 10.1007/s40265-024-02098-1
- By:
- Publication type:
- Article
Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders.
- Published in:
- Drugs, 2024, v. 84, n. 11, p. 1365, doi. 10.1007/s40265-024-02096-3
- By:
- Publication type:
- Article
Emerging Biologic Therapies for the Treatment of Atopic Dermatitis.
- Published in:
- Drugs, 2024, v. 84, n. 11, p. 1379, doi. 10.1007/s40265-024-02095-4
- By:
- Publication type:
- Article
Renin-Angiotensin-Aldosterone System Modulators in Adults with Hypertension: A Network Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Drugs, 2024, v. 84, n. 11, p. 1445, doi. 10.1007/s40265-024-02092-7
- By:
- Publication type:
- Article
Slowing the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes Using Four Pillars of Therapy: The Time to Act is Now.
- Published in:
- Drugs, 2024, v. 84, n. 11, p. 1337, doi. 10.1007/s40265-024-02091-8
- By:
- Publication type:
- Article
GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy.
- Published in:
- Drugs, 2024, v. 84, n. 11, p. 1347, doi. 10.1007/s40265-024-02090-9
- By:
- Publication type:
- Article